Manuel Litchman M.D.

CIK: 0001709485

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (100.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MBIO

MUSTANG BIO, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

MBIO
MUSTANG BIO, INC.
Apr 24, 2026
Tax Payment(F)
Direct
19 shares at avg. $0.75$14.25
MBIO
MUSTANG BIO, INC.
Apr 24, 2025
Tax Payment(F)
Direct
27 shares at avg. $1.24$33.48

		Type	Shares	Price		Ownership
Apr 24, 2026	MBIO MUSTANG BIO, INC.	Tax Payment(F)	19	$0.75	$14	Direct
Apr 24, 2025	MBIO MUSTANG BIO, INC.	Tax Payment(F)	27	$1.24	$33	Direct

1-2 of 2 transactions

About Litchman Manuel MD

Litchman Manuel MD (SEC CIK 0001709485) files insider reports with the SEC as President, CEO and Interim CFO of MUSTANG BIO, INC. (MBIO).

Signal8 holds 2 ownership filings by Litchman Manuel MD, all Form 4s, filed between Apr 28, 2025 and Apr 27, 2026. Those filings report 2 transactions, from Apr 24, 2025 to Apr 24, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Litchman Manuel MD's filings is in WALTHAM, MA.

Recent filings by Litchman Manuel MD

Apr 24, 2026: Tax withholding of MBIO shares (Form 4, code F).
Apr 24, 2025: Tax withholding of MBIO shares (Form 4, code F).

Other insiders filing for MUSTANG BIO, INC. (MBIO)

Fortress Biotech, Inc., 10% Owner
Herskowitz Neil, Director
Chill Adam J., Director
Jin David, Director

How to read Form 4 transaction codes